Cargando…
Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update
BACKGROUND: Diabetic foot (DF) is one of the most common and serious complications of diabetes mellitus (DM), which brings great psychological and economic pressure to patients. This study aimed to evaluate the efficacy of stem cells in the treatment of diabetic foot. METHODS: All relevant studies i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375292/ https://www.ncbi.nlm.nih.gov/pubmed/35964145 http://dx.doi.org/10.1186/s13287-022-03110-9 |
_version_ | 1784767934806097920 |
---|---|
author | Sun, Yuming Zhao, Jinhong Zhang, Lifang Li, Zhexuan Lei, Shaorong |
author_facet | Sun, Yuming Zhao, Jinhong Zhang, Lifang Li, Zhexuan Lei, Shaorong |
author_sort | Sun, Yuming |
collection | PubMed |
description | BACKGROUND: Diabetic foot (DF) is one of the most common and serious complications of diabetes mellitus (DM), which brings great psychological and economic pressure to patients. This study aimed to evaluate the efficacy of stem cells in the treatment of diabetic foot. METHODS: All relevant studies in Cochrane, Embase, PubMed, Web of Science, China National Knowledge Infrastructure, and WanFang databases were systematically searched for meta-analysis. The outcomes consisted of ulcer or wound healing rate, amputation rate, new vessels, ankle–brachial index (ABI), transcutaneous oxygen pressure (TcPO2), pain-free walking distance, and rest pain score. Dichotomous outcomes were described as risk ratios (RR) with 95% confidence intervals (CIs), while continuous data were presented as standardized mean differences (SMDs) with 95% CIs. Statistical analysis was performed with RevMan 5.3 software. RESULTS: A total of 14 studies with 683 participants were included in the meta-analysis. Meta-analysis showed that stem cell therapy was more effective than conventional therapy in terms of ulcer or wound healing rate [OR = 8.20 (5.33, 12.62)], improvement in lower extremity ischemia(new vessels) [OR = 16.48 (2.88, 94.18)], ABI [MD = 0.13 (0.04, 0.08)], TcO2[MD = 4.23 (1.82, 6.65)], pain-free walking distance [MD = 220.79 (82.10, 359.48)], and rest pain score [MD = − 1.94 (− 2.50, − 1.39)], while the amputation rate was significantly decreased [OR = 0.19 (0.10, 0.36)]. CONCLUSIONS: The meta-analysis of the current studies has shown that stem cells are significantly more effective than traditional methods in the treatment of diabetic foot and can improve the quality of life of patients after treatment. Future studies should conduct large-scale, randomized, double-blind, placebo-controlled, multicenter trials with high-quality long-term follow-up to demonstrate the most effective cell types and therapeutic parameters for the treatment of diabetic foot. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03110-9. |
format | Online Article Text |
id | pubmed-9375292 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93752922022-08-14 Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update Sun, Yuming Zhao, Jinhong Zhang, Lifang Li, Zhexuan Lei, Shaorong Stem Cell Res Ther Research BACKGROUND: Diabetic foot (DF) is one of the most common and serious complications of diabetes mellitus (DM), which brings great psychological and economic pressure to patients. This study aimed to evaluate the efficacy of stem cells in the treatment of diabetic foot. METHODS: All relevant studies in Cochrane, Embase, PubMed, Web of Science, China National Knowledge Infrastructure, and WanFang databases were systematically searched for meta-analysis. The outcomes consisted of ulcer or wound healing rate, amputation rate, new vessels, ankle–brachial index (ABI), transcutaneous oxygen pressure (TcPO2), pain-free walking distance, and rest pain score. Dichotomous outcomes were described as risk ratios (RR) with 95% confidence intervals (CIs), while continuous data were presented as standardized mean differences (SMDs) with 95% CIs. Statistical analysis was performed with RevMan 5.3 software. RESULTS: A total of 14 studies with 683 participants were included in the meta-analysis. Meta-analysis showed that stem cell therapy was more effective than conventional therapy in terms of ulcer or wound healing rate [OR = 8.20 (5.33, 12.62)], improvement in lower extremity ischemia(new vessels) [OR = 16.48 (2.88, 94.18)], ABI [MD = 0.13 (0.04, 0.08)], TcO2[MD = 4.23 (1.82, 6.65)], pain-free walking distance [MD = 220.79 (82.10, 359.48)], and rest pain score [MD = − 1.94 (− 2.50, − 1.39)], while the amputation rate was significantly decreased [OR = 0.19 (0.10, 0.36)]. CONCLUSIONS: The meta-analysis of the current studies has shown that stem cells are significantly more effective than traditional methods in the treatment of diabetic foot and can improve the quality of life of patients after treatment. Future studies should conduct large-scale, randomized, double-blind, placebo-controlled, multicenter trials with high-quality long-term follow-up to demonstrate the most effective cell types and therapeutic parameters for the treatment of diabetic foot. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-03110-9. BioMed Central 2022-08-13 /pmc/articles/PMC9375292/ /pubmed/35964145 http://dx.doi.org/10.1186/s13287-022-03110-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Sun, Yuming Zhao, Jinhong Zhang, Lifang Li, Zhexuan Lei, Shaorong Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title | Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title_full | Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title_fullStr | Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title_full_unstemmed | Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title_short | Effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
title_sort | effectiveness and safety of stem cell therapy for diabetic foot: a meta-analysis update |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375292/ https://www.ncbi.nlm.nih.gov/pubmed/35964145 http://dx.doi.org/10.1186/s13287-022-03110-9 |
work_keys_str_mv | AT sunyuming effectivenessandsafetyofstemcelltherapyfordiabeticfootametaanalysisupdate AT zhaojinhong effectivenessandsafetyofstemcelltherapyfordiabeticfootametaanalysisupdate AT zhanglifang effectivenessandsafetyofstemcelltherapyfordiabeticfootametaanalysisupdate AT lizhexuan effectivenessandsafetyofstemcelltherapyfordiabeticfootametaanalysisupdate AT leishaorong effectivenessandsafetyofstemcelltherapyfordiabeticfootametaanalysisupdate |